NLRP3 and Cognitive impairment: The activation of NLRP3 inflammasomes enhances AD progression by mediating chronic inflammatory responses [77], which are partly involved in restricting glial function, and mediating synaptic dysfunction and cognitive impairment [77], as well as BBB dysfunction [80].